Cargando…
索拉非尼联合化疗一线治疗FLT3-ITD突变阳性急性髓系白血病的临床对照研究
OBJECTIVE: To analyze the clinical features of acute myeloid leukemia patients with Fms-like tyrosine kinase 3 internal tandem duplication (FLT3-ITD) mutation and the therapeutic effect of sorafenib in combination with chemotherapy as first-line therapy for these patients. METHODS: Clinical features...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354192/ https://www.ncbi.nlm.nih.gov/pubmed/28565742 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2017.05.012 |
Ejemplares similares
-
索拉非尼联合化疗治疗FLT3-ITD突变阳性急性髓系白血病九例报告并文献复习
Publicado: (2015) -
索拉非尼联合CHAG方案诱导治疗10例FLT3-ITD突变阳性急性髓系白血病患者疗效观察
Publicado: (2016) -
索拉非尼单药治疗FLT3-ITD突变阳性急性髓系白血病14例疗效及安全性分析
Publicado: (2016) -
CLAG方案联合索拉非尼治疗难治性急性髓系白血病一例
Publicado: (2015) -
索拉非尼联合维奈克拉、阿扎胞苷方案诱导治疗FLT3-ITD突变阳性急性髓系白血病12例的疗效及安全性分析
Publicado: (2022)